drugset / Trial / NCT05416320

Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

NCT05416320

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this pilot study is to determine if calcipotriol shows potential to be an effective treatment for Central Centrifugal Cicatricial Alopecia (CCCA). This study aims to evaluate calcipotriol due to the possible anti-inflammatory effects that may affect the hair growth cycle.

Timeline

Start
2023-08
Primary completion
2023-11
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical